InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Yoshiyama Annie. Director active across 2 companies, notably Allogene Therapeutics, Inc.. In total, 4 reports have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €37k. History available since 24 January 2025. The latest transaction was filed on 21 April 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Yoshiyama Annie is a declarant linked to Allogene Therapeutics, Inc., where she is SVP, Finance. The record shows 4 filings in total, and among the recent sampled filings, sales for EUR 36662 between 2025-01-28 and 2026-04-23.